PLAT and meningococcemia: With respect to the field of fibrinolysis, some promising results were reported when treatment with recombinant tissue-plasminogen activator was used to restore fibrinolysis in a pediatric population with meningococcemia [51], however the high risk of hemorrhagic adverse effects precluded the possibility of carrying out further studies.